# Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR

> **NCT07492433** · — · NOT_YET_RECRUITING · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 800 (estimated)

## Conditions studied

- Intraluminal Thrombosis
- Tevar
- FET

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07492433
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-09-30
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07492433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07492433, "Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07492433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*